You are here: Industry Insights > cancer

News List

Merck and Palantir to form JV to advance cancer research pharmaceutical
November 21, 2018
Merck has signed a non-binding term sheet to establish a joint venture (JV) with data analytics firm Palantir Technologies to support the advancement of cancer research.
Boehringer partners with Epizyme to develop new cancer therapies pharmaceutical-technology
November 19, 2018
Boehringer Ingelheim has formed a global alliance with US-based biopharmaceutical firm Epizyme for the research, development and commercialisation of new potential cancer treatments.
World Menopause Month: moving from HRT to non-hormonal therapies pharmaceutical
November 19, 2018
World Menopause Month, which runs throughout October, raises awareness of menopause and associated disorders and diseases.
After historic win, Lilly partner Chi-Med’s Elunate flops in lung cancer fiercepharma
November 19, 2018
Hutchison China MediTech’s Elunate, which recently became the first China-made drug to win a major oncology approval, has flopped in a key non-small cell lung cancer trial.
Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE-Therapeutics b3cnewswire
November 17, 2018
NBE Therapeutics AG, a biopharmaceutical company developing next-generation immune-stimulatory antibody-drug conjugates (iADCs™) for improved cancer therapy, today announces the appointment of Dr. Anthony Tolcher to NBE's Scientific Advisory Board (SAB).
Obesity both feeds tumors and helps immunotherapy kill cancer worldpharmanews
November 15, 2018
A groundbreaking new study by UC Davis researchers has uncovered why obesity both fuels cancer growth and allows blockbuster new immunotherapies to work better against those same tumors. The paradoxical findings, published today in Nature Medicine, give c
Obesity both feeds tumors and helps immunotherapy kill cancer worldpharmanews
November 15, 2018
A groundbreaking new study by UC Davis researchers has uncovered why obesity both fuels cancer growth and allows blockbuster new immunotherapies to work better against those same tumors. The paradoxical findings, published today in Nature Medicine, give c
The top 10 cancer drug makers of 2024 fiercepharma
November 15, 2018
At first glance, the list of cancer drug makers predicted to head the field by 2024 may not look so different from the list of top-selling cancer drug makers in 2017.
Planning and implementing biomarker testing for immuno-oncology trials fiercepharma
November 15, 2018
Foundations laid by important cancer biology and immunology research throughout the last decades have led to game-changing clinical breakthroughs in the field of immuno-oncology
Genomic profiling offers hope for rare cancer treatments pharmaceutical-technology
November 14, 2018
A clinical trial led by Walter and Eliza Hall Institute of Medical Research in Australia has demonstrated that genomic profiling could help match rare cancer patients with appropriate treatments.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page